This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Her Majesty the Queen in Right of Canada, as Represented by the Minister of National Defence, Oncolytics Biotech Inc.. Active years: 2022-2026.
Company Filing History:

Years Active: 2022-2026
Title: Innovations of Jyoti Latawa
Introduction
Jyoti Latawa is an accomplished inventor based in Mont-Royal, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing antibodies in plants. With a total of 2 patents, his work has the potential to impact therapeutic and prophylactic applications.
Latest Patents
One of Jyoti Latawa's latest patents is focused on viral extraction from cell culture. This patent describes a method for producing ricin antibodies that bind to the ricin B chain. The method involves introducing nucleic acid molecules encoding the heavy and light chain variable regions of the antibody into a plant or plant cell. Following this, the plant or plant cell is grown to obtain a plant that expresses the antibody or antibody fragment. This innovation also encompasses anti-ricin B chain antibodies and their fragments, along with methods for their therapeutic use.
Career Highlights
Throughout his career, Jyoti Latawa has worked with notable organizations, including Her Majesty the Queen in Right of Canada, as Represented by the Minister of National Defence, and Oncolytics Biotech Inc. His experience in these institutions has allowed him to refine his expertise in biotechnology and innovation.
Collaborations
Jyoti has collaborated with several professionals in his field, including J Christopher Hall and Ashley J Meyers. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jyoti Latawa's innovative work in biotechnology, particularly in the production of antibodies in plants, showcases his dedication to advancing medical science. His contributions are poised to make a significant impact in therapeutic applications.